BILLERICA, Mass., March 23, 2020 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS), an orthopedic arthroplasty medical technology company, today announced proactive steps it is taking and planning to mitigate the negative financial and operational impacts of the coronavirus (COVID-19) pandemic. “Our core product areas of knee and hip surgery are being impacted in unprecedented ways by …

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone